Other
Convertible debentures
Guardant Health Convertible debentures decreased by 0.0% to $1.5B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 34.7%, from $1.12B to $1.5B. Over 5 years (FY 2020 to FY 2025), Convertible debentures shows an upward trend with a 13.3% CAGR.
Analysis
StatementBalance Sheet Statement
SectionOther
First reportedQ4 2019
Last reportedQ1 2026May 7, 2026
Metric ID:
other_convertible_debt_noncurrentHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.13B | $1.13B | $1.13B | $1.14B | $1.14B | $1.14B | $1.14B | $1.14B | $1.14B | $1.14B | $1.14B | $1.14B | $1.14B | $1.14B | $1.14B | $1.12B | $1.12B | $1.11B | $1.5B | $1.5B |
| QoQ Change | — | +0.1% | +0.1% | +0.1% | +0.1% | +0.1% | +0.1% | +0.1% | +0.1% | +0.1% | +0.1% | +0.1% | +0.1% | +0.1% | +0.1% | -2.3% | -0.1% | -0.1% | +34.9% | -0.0% |
| YoY Change | — | — | — | — | +0.2% | +0.2% | +0.2% | +0.2% | +0.2% | +0.2% | +0.2% | +0.2% | +0.2% | +0.2% | +0.2% | -2.1% | -2.3% | -2.4% | +31.6% | +34.7% |
Range$1.11B – $1.5B
CAGR+6.1%
Avg YoY Growth+3.9%
Median YoY Growth+0.2%
Convertible debentures at Other Companies
Frequently Asked Questions
- What is Guardant Health's convertible debentures?
- Guardant Health (GH) reported convertible debentures of $1.5B in Q1 2026.
- How has Guardant Health's convertible debentures changed year-over-year?
- Guardant Health's convertible debentures increased by 34.7% year-over-year, from $1.12B to $1.5B.
- What is the long-term trend for Guardant Health's convertible debentures?
- Over 5 years (2020 to 2025), Guardant Health's convertible debentures has grown at a 13.3% compound annual growth rate (CAGR), from $806.29M to $1.5B.